Dr Reddy's Laboratories Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Metsmall GV 1 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Metsmall GV 1 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Metsmall GV 1 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Metsmall GV 1 Tablet SR.
Metsmall GV 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Metsmall GV 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Metsmall GV 1 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Metsmall GV 1 Tablet SR is a combination medication containing Glimepiride, Metformin, and Voglibose. This medication is used to manage type 2 diabetes mellitus (DM). It helps lower blood glucose levels in adults when taken alongside dietary adjustments and regular exercise. Glimepiride increases insulin release from the pancreas, Metformin reduces glucose production in the liver, and Voglibose inhibits alpha-glucosidase, impacting postprandial (after meal) glucose levels.
Possible side effects associated with Metsmall GV 1 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Avoid using Metsmall GV 1 Tablet SR if you are allergic to any of the ingredients or excipients. It is also avoided for individuals with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcers, and underlying metabolic acidosis including diabetic ketoacidosis.
No, combining Metsmall GV 1 Tablet SR with alcohol is not recommended. This combination may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Metsmall GV 1 Tablet SR can contribute to hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This is more likely when missing meals, consuming alcohol, exercising excessively, or taking other antidiabetic medications concurrently. Regular blood sugar monitoring is crucial.
Store Metsmall GV 1 Tablet SR in its original packaging, tightly closed, according to the label's instructions. Do not discard unused medication. Ensure pets, children, and unauthorized individuals do not access it.